EKR Therapeutics to Present at the 2009 UBS Global Life Sciences Conference
BEDMINSTER, N.J.-(Business Wire)-September 17, 2009 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing critical-care products for the hospital setting, today announced that Howard Weisman, CEO & President, will present at the UBS Global Life Sciences Conference on Tuesday, September 22 at 10:00 a.m. ET. The conference will be held from September 21 - 23, 2009 at the Grand Hyatt New York, Park Avenue at Grand Central in New York City.
A webcast of the live presentation will be available online through the EKR Media Center at www.EKRtx.com/presentations.php. The presentation will also be archived for approximately 60 days and available for replay by visiting the EKR Media Center.
About EKR Therapeutics
EKR Therapeutics, with 2008 revenues surpassing $200 million, initiated operations in June 2006 as an acute-care specialty pharmaceutical company. Led by industry veterans and backed by the strength of is field force of hospital product specialists and its commitment to customer service and medical education, EKR has been organized to be a class leader in acquiring, developing, and commercializing products to improve in-patient care, speed recovery, and achieve optimal outcomes. For additional information visit the company’s website at www.ekrtx.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
